Thalidomide for Treating Metastatic Hepatocellular Carcinoma: A Pilot Study

BACKGROUND: Thalidomide has been reported to have antitumor activity for treating metastatic hepatocellular carcinoma (HCC). We evaluated the safety and efficacy of using thalidomide for treating selected patients with unresectable or metastatic HCC, and their disease was refractory to systemic chem...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Han, Sang Hoon, Park, Se Hoon, Kim, Jung Ho, Lee, Jong Jun, Kwon, So Young, Kwon, Oh Sang, Kim, Sun Suk, Kim, Ju Hyun, Kim, Keon Kug, Park, Yeon Ho, Lee, Jeong Nam, Nam, Eunmi, Bang, Soo-Mee, Cho, Eun Kyung, Shin, Dong Bok, Lee, Jae Hoon
Formato: Artigo
Idioma:Inglês
Publicado: The Korean Association of Internal Medicine 2006
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3891026/
https://ncbi.nlm.nih.gov/pubmed/17249503
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2006.21.4.225
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares